Highly potent fluorescent analogues of the opioid peptide [Dmt 1]DALDA

Peptides

Volumn 24, Issue 8, 2003, Pages 1195-1200

  Berezowska, Irena ^a   Chung, Nga N ^a   Lemieux, Carole ^a   Zelent, Bogumil ^b   Szeto, Hazel H ^c   Schiller, Peter W ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Antinociception; Fluorescence quantum yield; Fluorescence spectroscopy; Fluorescent opioid peptide analogues; Opioid activity profile in vitro; Opioid peptides; Dmt1 DALDA

Indexed keywords

BETA ANTHRANILOYL LEVO ALPHA BETA DIAMINOPROPIONIC ACID; BETA DANSYL LEVO ALPHA BETA DIAMINOPROPIONIC ACID; BIOPOLYMER; LYSINE DERIVATIVE; MU OPIATE RECEPTOR AGONIST; OPIATE PEPTIDE; PROPIONIC ACID DERIVATIVE; TYROSYL DEXTRO ARGINYLPHENYLALANYLLYSINAMIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FLAME PHOTOMETRY; FLUORESCENCE; GUINEA PIG; ILEUM; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTUM MECHANICS; TAIL FLICK TEST; TISSUE DISTRIBUTION;

CAVIA PORCELLUS; SUS SCROFA;

EID: 0242663468     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2003.07.004     Document Type: Article

References (24)

1. Arttamangkul S., Alvarez-Maubecin V., Thomas G., Williams G.T., Grandy D.K. Binding and internalization of fluorescent opioid peptide conjugates in living cells. Mol. Pharmacol. 58:2000;1570-1580.
2. Chen R.F. Fluorescence of dansyl amino acids in organic solvents and protein solutions. Arch. Biochem. Biophys. 120:1967;609-620.
3. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3102.
4. DiMaio J., Nguyen T.M.-D., Lemieux C., Schiller P.W. Synthesis and pharmacological characterization in vitro of cyclic enkephalin analogues: effects of conformational constraints on opiate receptor selectivity. J. Med. Chem. 25:1982;1432-1438.
5. Gaudriault G., Nouel D., Dal Farra C., Beaudet A., Vincent J.-P. Receptor-induced internalization of selective peptidic μ and δ opioid ligands. J. Biol. Chem. 272:1997;2880-2888.
6. Gillan M.G.C., Kosterlitz H.W., Magnan J. Unexpected antagonism in the rat vas deferens by benzomorphans which are agonists in other pharmacological tests. Br. J. Pharmacol. 72:1981;13-15.
7. Henderson G., Hughes J., Kosterlitz H.W. A new example of a morphine sensitive neuroeffector junction. Br. J. Pharmacol. 46:1972;764-766.
8. Kosterlitz H.W., Watt A.J. Kinetic parameters of nicotinic agonists and antagonists with particular reference to N-allylnoroxymorphone (naloxone). Br. J. Pharmacol. 33:1968;266-276.
9. Lipkowski A.W., Misicka A., Kosson D., Kosson P., Lachwa-From M., Brodzik-Bienkowska A.et al. Biological properties of a new fluorescent biphalin fragment analogue. Life Sci. 70:2002;893-897.
10. Parker C.W., Godt S.M., Johnson M.C. Fluorescent probes for the study of the antibody-hapten reaction. II. Binding of the 5-dimethylaminonaphthylene-1- sulfonamido group by homologous rabbit antibody. Biochemistry. 6:1967;3408-3416.
11. Paton W.D.M. The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea pig ileum. Br. J. Pharmacol. 12:1957;119-127.
12. 2 and its fluorinated aromatic amino acid derivatives. Chem. Pharm. Bull. 39:1991;2316-2318.
13. Sasaki Y., Suto T., Ambo A., Ouchi H., Yamamoto Y. Biological properties of opioid peptides replacing Tyr at position 1 by 2,6-dimethyl-Tyr. Chem. Pharm. Bull. 47:1999;1506-1509.
14. 21-ACTH-(1-24)-tetrakosipeptide. Proc. Natl. Acad. Sci. U.S.A. 69:1972;975-979.
15. Schiller P.W., Lipton A., Horrobin D.F., Bodanszky M. Unsulfated C-terminal 7-peptide of cholecystokinin: a new ligand of the opiate receptor. Biochem. Biophys. Res. Commun. 85:1978;1332-1338.
16. Schiller P.W., Nguyen T.M.-D., Chung N.N., Lemieux C. Dermorphin analogues carrying an increased positive net charge in their "message" domain display extremely high μ-opioid receptor selectivity. J. Med. Chem. 32:1989;698-703.
17. Schiller PW, Weltrowska G, Schmidt R, Nguyen TM-D, Berezowska I, Chen Y, et al. Opioid peptide analogs with novel activity profiles as potential therapeutic agents for use in analgesia. In: Shimonishi Y, editor. Peptide science - present and future. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1999. p. 665-9.
18. Schiller P.W., Nguyen T.M.-D., Berezowska I., Dupuis S., Weltrowska G., Chung N.N.et al. Synthesis and in vitro opioid activity profiles of DALDA analogues. Eur. J. Med. Chem. 35:2000;895-901.
19. 21- adrenocorticotropin-(1-24)-tetrakosipeptid. Helv. Chim. Acta. 54:1971;897-904.
20. 1]DALDA. J. Pharmacol. Exp. Ther. 297:2001;364-371.
21. Taki M., Hohsaka T., Murakami H., Taira K., Sisido M. A non-natural amino acid for efficient incorporation into proteins as a sensitive fluorescent probe. FEBS Lett. 507:2001;35-38.
22. 65-analogue. Comparison of the binding properties of methionine- and leucine-enkephalin. Eur. J. Pharmacol. 58:1979;11-18.
23. Zhao G.-M., Wu D., Soong Y., Shimoyama M., Berezowska I., Schiller P.W. et al. Profound spinal tolerance after repeated exposure to a highly selective μ-opioid peptide agonist: role of δ-opioid receptors. J. Pharmacol. Exp. Ther. 302:2002;188-196.
24. Zhao K., Luo G., Zhao G.-M., Schiller P.W., Szeto H.H. Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide. J. Pharmacol. Exp. Ther. 304:2003;425-432.